These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 38995299

  • 1. The Relationship between Serum TWEAK Levels and Carotid Intima-media Thickness in Patients with Fabry Disease.
    Turkmen K, Baloglu I, Aykut T, Demir S, Altın E, Akguzel ZA, Kocabas M, Yerlikaya FH.
    Saudi J Kidney Dis Transpl; 2023 Sep 01; 34(5):406-415. PubMed ID: 38995299
    [Abstract] [Full Text] [Related]

  • 2. Soluble TWEAK independently predicts atherosclerosis in renal transplant patients.
    Turkmen K, Tonbul HZ, Erdur FM, Toker A, Biyik Z, Ozbiner H, Gaipov A, Gul EE, Kayrak M, Solak Y, Ozbek O, Turk S, Covic A.
    BMC Nephrol; 2013 Jul 12; 14():144. PubMed ID: 23849432
    [Abstract] [Full Text] [Related]

  • 3. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
    Icli A, Cure MC, Cure E, Arslan S, Unal M, Sakiz D, Ozucan M, Toker A, Turkmen K, Kucuk A.
    Acta Medica (Hradec Kralove); 2018 Jul 12; 61(3):86-92. PubMed ID: 30543512
    [Abstract] [Full Text] [Related]

  • 4. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
    Dirajlal-Fargo S, Sattar A, Kulkarni M, Funderburg N, McComsey GA.
    HIV Clin Trials; 2017 Jul 12; 18(4):156-163. PubMed ID: 28828963
    [Abstract] [Full Text] [Related]

  • 5. Inverse Relationship between Plasma Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Carotid Intima-Media Thickness among Patients Undergoing Hemodialysis and Peritoneal Dialysis.
    Shi X, Qiu B, Shen H, Feng S, Fu J.
    Cardiorenal Med; 2020 Jul 12; 10(3):137-144. PubMed ID: 32126565
    [Abstract] [Full Text] [Related]

  • 6. The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients.
    Ates I, Ozkayar N, Akyel F, Topcuoglu C, Akyel S, Barça AN, Dede F.
    BMC Nephrol; 2014 Oct 01; 15():159. PubMed ID: 25273526
    [Abstract] [Full Text] [Related]

  • 7. Changes in Soluble TWEAK Concentrations, but Not Those in Amyloid-β(1-40), Are Associated with a Decrease in Carotid Intima-Media Thickness after Bariatric Surgery in Obese Women.
    Gómez-Martin JM, Aracil E, Insenser M, de la Peña G, Lasunción MA, Galindo J, Escobar-Morreale HF, Balsa JA, Botella-Carretero JI.
    Obes Facts; 2020 Oct 01; 13(3):321-330. PubMed ID: 32388504
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy.
    Liu SY, Chen J, Li YF.
    J Diabetes Investig; 2018 Sep 01; 9(5):1182-1188. PubMed ID: 29489069
    [Abstract] [Full Text] [Related]

  • 9. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V, Sastre C, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.
    Clin J Am Soc Nephrol; 2016 Mar 07; 11(3):413-22. PubMed ID: 26728587
    [Abstract] [Full Text] [Related]

  • 10. Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases.
    Fernández-Laso V, Sastre C, Valdivielso JM, Fernández E, Martín-Ventura JL, Egido J, Blanco-Colio LM.
    Atherosclerosis; 2015 Apr 07; 239(2):358-63. PubMed ID: 25681674
    [Abstract] [Full Text] [Related]

  • 11. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.
    Fernández-Laso V, Méndez-Barbero N, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.
    Atherosclerosis; 2017 May 07; 260():130-137. PubMed ID: 28390291
    [Abstract] [Full Text] [Related]

  • 12. Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.
    Sabry HH, Sabry JH, Daifalla AEH, Akl EM, Hamed AM, Torky AAA.
    Vasc Health Risk Manag; 2018 May 07; 14():145-152. PubMed ID: 30022835
    [Abstract] [Full Text] [Related]

  • 13. The relationships between serum sTWEAK, FGF-23 levels, and carotid atherosclerosis in renal transplant patients.
    Gungor O, Kismali E, Sisman AR, Kircelli F, Carrero JJ, Tatar E, Asci G, Toz H.
    Ren Fail; 2013 May 07; 35(1):77-81. PubMed ID: 23101788
    [Abstract] [Full Text] [Related]

  • 14. Assessment of Atherosclerosis in Sle Patients by Measuring Carotid Intima Media Thickness: A Cross Sectional Study.
    Mukherjee R, Bhattacharya R, Naiya SB, Mondal SS, Lyngdoh L.
    J Assoc Physicians India; 2022 Apr 07; 70(4):11-12. PubMed ID: 35443433
    [Abstract] [Full Text] [Related]

  • 15. Serum fibroblast growth factor 23 levels do not correlate with carotid intima-media thickness in patients with chronic kidney disease.
    Kaya B, Seyrek N, Paydas S, Karayaylali İ, Balal M, Aikimbaev K.
    Saudi J Kidney Dis Transpl; 2019 Apr 07; 30(5):1010-1021. PubMed ID: 31696838
    [Abstract] [Full Text] [Related]

  • 16. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
    Valdivielso JM, Coll B, Martín-Ventura JL, Moreno JA, Egido J, Fernández E, Blanco-Colio LM.
    J Nephrol; 2013 Apr 07; 26(6):1105-13. PubMed ID: 23475462
    [Abstract] [Full Text] [Related]

  • 17. Serum adipokine levels in type 1 diabetic patients: association with carotid intima media thickness.
    Yazıcı D, Yavuz D, Öğünç AV, Sirikçi Ö, Toprak A, Deyneli O, Akalın S.
    Metab Syndr Relat Disord; 2012 Feb 07; 10(1):26-31. PubMed ID: 21933002
    [Abstract] [Full Text] [Related]

  • 18. Serum Ferritin Relates to Carotid Intima-Media Thickness in Offspring of Fathers With Higher Serum Ferritin Levels.
    Prats-Puig A, Moreno M, Carreras-Badosa G, Bassols J, Ricart W, López-Bermejo A, Fernández-Real JM.
    Arterioscler Thromb Vasc Biol; 2016 Jan 07; 36(1):174-80. PubMed ID: 26586658
    [Abstract] [Full Text] [Related]

  • 19. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
    Yamamoto R, Sacks FM, Hu FB, Rosner B, Furtado JD, Aroner SA, Ferrannini E, Baldi S, Kozakova M, Balkau B, Natali A, Jensen MK, RISC Investigators.
    Atherosclerosis; 2018 Feb 07; 269():92-99. PubMed ID: 29351856
    [Abstract] [Full Text] [Related]

  • 20. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
    Fan WC, Huang CC, Yang YY, Lin A, Lee KC, Hsieh YC, Fung CP, Hsu HC, Hou MC, Lin HC.
    J Microbiol Immunol Infect; 2017 Dec 07; 50(6):905-914. PubMed ID: 26872435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.